Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group
-
Published:2024-06-04
Issue:1
Volume:15
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Freyer GillesORCID,
Floquet AnneORCID,
Tredan Olivier,
Carrot Aurore,
Langlois-Jacques Carole,
Lopez Jonathan,
Selle FrédéricORCID,
Abdeddaim Cyril,
Leary Alexandra,
Dubot-Poitelon Coraline,
Fabbro MichelORCID,
Gladieff Laurence,
Lamuraglia MicheleORCID
Publisher
Springer Science and Business Media LLC